Showing results (531-540 of 557) with videos related to
Sort By:
Pageof 56
Journal of the American Academy of Child and Adolescent Psychiatry|August 19, 2003
Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000Laurence L Greenhill, Benedetto Vitiello, Howard Abikoff, et al.Haematologica|February 27, 2025
Community respiratory viruses are generally well-tolerated in hematopoietic stem cell transplant recipients: a brief report from the TRANSPIRE studyMeghan Haney, Arfa Ashraf, Kelly E Lake, et al.Journal of the American Academy of Child and Adolescent Psychiatry|August 19, 2003
Review of safety assessment methods used in pediatric psychopharmacologyLaurence L Greenhill, Benedetto Vitiello, Mark A Riddle, et al.Archives of General Psychiatry|September 9, 2009
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thoughtPeter Rabins, Brian S Appleby, Jason Brandt, et al.Journal of the American Heart Association|August 29, 2023
Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE TrialMary O Whipple, Angela Fidler Pfammatter, Bonnie Spring, et al.Journal of Consulting and Clinical Psychology|January 15, 2014
Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trialScott N Compton, Tara S Peris, Daniel Almirall, et al.Antimicrobial Agents and Chemotherapy|September 18, 2013
Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapyBoudewijn L M de Jonge, Grant K Walkup, Sushmita D Lahiri, et al.Journal of the American Academy of Child and Adolescent Psychiatry|July 4, 2020
Little Doubt That CBT Works for Pediatric OCDEric A Storch, Tara S Peris, Alessandro De Nadai, et al.Scientific Reports|July 15, 2015
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerasesGregory S Basarab, Gunther H Kern, John McNulty, et al.Nature Chemical Biology|April 21, 2015
Translating slow-binding inhibition kinetics into cellular and in vivo effectsGrant K Walkup, Zhiping You, Philip L Ross, et al.Pageof 56